Preimplantation Genetic Testing  (PGT) increase successful IVF cycle at first embryo transfer by lowering risk of miscarriage. PGT also help in reducing the risk of having baby with chromosomal abnormalities. Most common reason for Preimplantation Genetic Screening (PGD) are specific gene conditions like sickle cell anemia, cystic fibrosis, and structural changes of parental chromosomes. In couple where mother is older than 35 and at risk for a child with chromosomal problem may benefit from Preimplantation Genetic Screening (PGD). Most of the PGT is performed by using trophectoderm biopsy and strategy of comprehensive chromosome screening. PGT-A for aneuploidy and PGT-SR for chromosomal structural re-arrangements has become effective approaches for selection of euploid embryos for transfer and for lowering the risk of implantation failure & miscarriage in clinical treatment of IVF (In-vitro fertilization). PGT is done by different methods like Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers, etc. Newer techniques like genome sequencing and microarray has become common methods of genetic testing. PGT test for around 400 different single-gene disorders which includes, sickle cell anemia, cystic fibrosis, Huntington’s disease, and Tay-Sachs. Newer techniques like genome sequencing and microarray has become common methods of genetic testing. However, applications of Preimplantation Genetic Testing has given positive impact on target market growth.

The report “Preimplantation Genetic Testing Market, By Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), By Technology (Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers and Others), By Application (Aneuploidy, Single Gene Disorders, HLA Typing, X-Linked Disorders, and Others), By End-Users (Research Laboratories, Fertility Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Highlights:

• In October 2018, Agilent Technologies has announced the launch of Agilent ‘OnePGT’ a unique next generation sequencing (NGS) solution for PGT (Preimplantation Genetic Testing) solution. Newly launched ‘OnePGT’ solution will empower the fertility specialists for attaining comprehensive insights and improving ranking of IVF (in vitro fertilized) embryos. Newly launched ‘OnePGT’ solution will help in allowing parallel detection of multiple monogenic disorders (PGT-M), aneuploidies (PGT-A), and translocations (PGT-SR), etc., on single biopsy.

• In October 2018, CooperSurgical Inc., has launched the new ‘PGTai technology’ platform and ‘ERPeak’ Endometrial Receptivity test. Newly launched ‘PGTai technology’ provides robust data analysis with reporting & interpretation. Newly developed ‘ERPeak’ Endometrial Receptivity test provides accurate & reliable detection of receptivity status of women’s emdometrium and optimal embryo transfer timing.
• In May 2017, Natera has launched the new ‘Vistara’ a single gene mutation NIPT (non-invasive prenatal test) for screening single gene disorders. Newly launched ‘Vistara’ is screens for new mutations in 30 genes which has combined incidence rate of nearly 1 in 600 and higher than Down syndrome. Screening will help to detect single gene disorders early in pregnancy and will provide important next step in screening for fetuses with chromosomal imbalance and major anatomic abnormalities.

Analyst View:

The key factor driving the growth of the Preimplantation Genetic Testing (PGT) market is decreasing fertility rates and rapid growth in urbanization. PGT has become a major diagnostic tool for prevention of transmission of genetic disorder. A couple who has certain genetic aberrations with high risk of having babies, PGT help in having babies. PGT-M also help in reducing early miscarriages, trauma of multiple failed IVF cycles, and thus, helps in advanced maternal age for preventing birth of syndromic child. PGT-M help in protecting the child from inherited monogenic disorders. PGT increase successful IVF cycle at first embryo transfer by lowering risk of miscarriage. PGT also help in reducing the risk of having baby with chromosomal abnormalities. However, applications of PGT and decreasing fertility rates is expected to boost the demand for Preimplantation Genetic Testing market growth over the forecast period. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Preimplantation Genetic Testing Market, By Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), By Technology (Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers and Others), By Application (Aneuploidy, Single Gene Disorders, HLA Typing, X-Linked Disorders, and Others), By End-Users (Research Laboratories, Fertility Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report

Preimplantation Genetic Testing Market accounted for US$ 714.4 million in 2024 and is estimated to be US$ 1742.5 million by 2034 and is anticipated to register a CAGR of 10.30%. The Preimplantation Genetic Testing Market is segmented based on Type, Technology, Application, End-Users and Region

• Based on Type, Preimplantation Genetic Testing Market is segmented into Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis.
• Based on Technology, Preimplantation Genetic Testing Market is segmented into Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers and others.
• Based on Application Preimplantation Genetic Testing Market is segmented into Aneuploidy, Single Gene Disorders, HLA Typing, X-Linked Disorders, and others.
• Based on End-Users, Preimplantation Genetic Testing Market is segmented into Research Laboratories, Fertility Clinics, and others.
• By Region, the Preimplantation Genetic Testing Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Preimplantation Genetic Testing Market:

The prominent players operating in the Preimplantation Genetic Testing  Market includes, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Illumina Inc., Perkin Elmer Inc., Agilent Technologies Inc., CooperSurgical Inc., Natera Inc., Bioarray S.L., MedGenome Labs Ltd., Eurofins Genoma and others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com